>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
粪便检测在炎症性肠病疾病活动度评估中的应用现状
作者:冉雪梅1  陈洪2 
单位:1. 东南大学 医学院, 江苏 南京 210009;
2. 东南大学附属中大医院 消化科, 江苏 南京 210009
关键词:炎症性肠病 疾病活动度 粪便钙卫蛋白 粪便免疫检测 
分类号:R446.13;R574.62
出版年·卷·期(页码):2019·38·第三期(550-554)
摘要:

炎症性肠病是消化道反复发作的一种非特异性炎症性疾病。内镜检查是评估疾病活动度的金标准,但该检查因具有侵入性而限制了其使用。研究证实,粪便检测在评估炎症性肠病疾病活动度方面有良好的应用价值。作者就粪便钙卫蛋白检测、粪便免疫化学检测在评估炎症性肠病疾病活动度中的应用现状作一综述。

参考文献:

[1] 中华医学会消化病学分会炎症性肠病学组.炎症性肠病诊断与治疗的共识意见(2012年·广州)[J].中华内科杂志,2012,51(10):818-831.
[2] COLOMBEL J F,RUTGEERTS P,REINISCH W,et al.Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis[J].Gastroenterology,2011,141(4):1194-1201.
[3] AFBJÖRKESTEN C G,NIEMINEN U,SIPPONEN T,et al.Mucosal healing at 3 months predicts long-term endoscopic remission in anti-TNF-treated luminal Crohn's disease[J].Scand J Gastroenterol,2013,48(5):543-551.
[4] LICHTENSTEIN G R,YAN S,BALA M,et al.Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries[J].Am J Gastroenterol,2004,99(1):91-96.
[5] VERMEIRE S,VAN A G,RUTGEERTS P.Laboratory markers in IBD:useful,magic,or unnecessary toys[J].Gut,2006,55(3):426-431.
[6] SUTHERLAND A D,GEARRY R B,FRIZELLE F A.Review of fecal biomarkers in inflammatory bowel disease[J].Dis Colon Rectum,2008,51(8):1283-1291.
[7] 叶院宁,汪芳裕.粪便钙卫蛋白检测在炎症性肠病中的应用价值[J].医学研究生学报,2015(8):865-869.
[8] SIPPONEN T,SAVILAHTI E,KOLHO K L,et al.Crohn's disease activity assessed by fecal calprotectin and lactoferrin:correlation with Crohn's disease activity index and endoscopic findings[J].Inflamm Bowel Dis,2008,14(1):40-46.
[9] SCHOEPFER A M,BEGLINGER C,STRAUMANN A,et al.Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's Disease(SES-CD) than CRP, blood leukocytes,and the CDAI[J].Am J Gastroenterol,2010,105(1):162-169.
[10] KOULAOUZIDIS A,DOUGLAS S,PLEVRIS J N.Lewis score correlates more closely with fecal calprotectin than capsule endoscopy Crohn's disease activity index[J].Dig Dis Sci,2012,57(4):987-993.
[11] STAWCZYKEDER K,EDER P,LYKOWSASZUBER L,et al.Is faecal calprotectin equally useful in all Crohn's disease locations?A prospective,comparative study[J].Arch Med Sci,2015,11(2):353-361.
[12] KOPYLOV U,YUNG D E,ENGEL T,et al.Fecal calprotectin for the prediction of small-bowel Crohn's disease by capsule endoscopy:a systematic review and meta-analysis[J].Eur J Gastroenterol Hepatol,2016,28(10):1137-1144.
[13] SCHOEPFER A M,BEGLINGER C,STRAUMANN A,et al.Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index,C-reactive protein,platelets,hemoglobin,and blood leukocytes[J].Inflamm Bowel Dis,2013,19(2):332-341.
[14] D'HAENS G,FERRANTE M,VERMEIRE S,et al.Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease[J].Inflamm Bowel Dis,2012,18(12):2218-2224.
[15] KAWASHIMA K,ISHIHARA S,YUKI T,et al.Fecal calprotectin level correlated with both endoscopic severity and disease extent in ulcerative colitis[J].BMC Gastroenterol,2016,16(1):47.
[16] 陈金敏,周经委,邓飞鸿,等.非侵入性分子标志物评估临床缓解期炎症性肠病内镜活动度价值研究[J].中国实用内科杂志,2016,36(11):971-974.
[17] LIN J F,CHEN J M,ZUO J H,et al.Meta-analysis:fecal calprotectin for assessment of inflammatory bowel disease activity[J].Inflamm Bowel Dis,2014,20(8):1407-1415.
[18] RØSETH A G,AADLAND E,GRZYB K.Normalization of faecal calprotectin:a predictor of mucosal healing in patients with inflammatory bowel disease[J].Scand J Gastroenterol,2004,39(10):1017-1020.
[19] YAMAGUCHI S,TAKEUCHI Y,ARAI K,et al.Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis[J].J Gastroenterol Hepatol,2016,31(1):93-98.
[20] NAKARAI A,KATO J,HIRAOKA S,et al.Evaluation of mucosal healing of ulcerative colitis by a quantitative fecal immunochemical test[J].Am J Gastroenterol,2013,108(1):83-89.
[21] TAKASHIMA S,KATO J,HIRAOKA S,et al.Evaluation of mucosal healing in ulcerative colitis by fecal calprotectin vs.fecal immunochemical test[J].Am J Gastroenterol,2015,110(6):873-880.
[22] YE L,CHEN W,CHEN B Q,et al.Levels of Faecal calprotectin and magnetic resonance enterocolonography correlate with severity of small bowel Crohn's disease:a retrospective cohort study[J].Sci Rep,2017,7(1):1970.
[23] SANDBORN W J,PANÉS J,ZHANGH,et al.Correlation between concentrations of fecal calprotectin and outcomes of patients with ulcerative colitis in a phase 2 trial[J].Gastroenterology,2016,150(1):96-102.
[24] VILKIN A,ROZEN P,LEVI Z,et al.Performance characteristics and evaluation of an automated-developed and quantitative,immunochemical,fecal occult blood screening test[J].Am J Gastroenterol,2005,100(11):2519-2525.
[25] SHI H Y,CHAN F,CHAN A,et al.Accuracy of faecal immunochemical test to predict endoscopic and histological healing in ulcerative colitis:a prospective study based on validated histological scores[J].J Crohns Colitis,2017,11(9):1071-1077.
[26] NAKARAI A,KATO J,HIRAOKA S,et al.Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results,mucosal healing, and risk of relapse[J].World J Gastroenterol,2016,22(21):5079-5087.
[27] INOKUCHI T,KATO J,HIRAOKA S,et al.Fecal immunochemical test versus fecal calprotectin for prediction of mucosal healing in Crohn's disease[J].Inflamm Bowel Dis,2016,22(5):1078-1085.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 412693 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364